TY - CHAP A1 - Shani Golan A2 - Michaella Goldstein A3 - Anat Loewenstein ED1 - Giuseppe Lo Giudice Y1 - 2013-06-12 PY - 2013 T1 - Anti VEGF Agents for Age Related Macular Degeneration N2 - Age-related macular degeneration (AMD) is the leading cause of irreversible central vision loss in developed countries.There have been rapid developments of therapies that today can halt or even reverse aspects of vision loss resulting from AMD among those most severely affected, and there is promise of future therapies that may prevent vision loss. This book provides an overview about AMD; an update on the current understanding of AMD, pathophysiology, the use of diagnostic tests, the management of both non-neovascular and neovascular AMD as well as future directions in treatment and its limitations. It also looks into the future with potential treatment options that are now under investigation in clinical trials. BT - Age-Related Macular Degeneration SP - Ch. 5 UR - https://doi.org/10.5772/54198 DO - 10.5772/54198 SN - PB - IntechOpen CY - Rijeka Y2 - 2021-09-22 ER -